Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03570840 · ClinicalTrials.gov registry record
Pediatric Metabolic Syndrome Study
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 477
- Enrollment target
NCT03570840: Completed study, sponsored by Medical University of South Carolina.
NCT03570840 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 477 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03570840 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 477 participants
- Enrollment target
Study Summary
The Pediatric Metabolic Syndrome Study is an observational study being conducted at the Medical University of South Carolina to investigate cardiometabolic risk parameters in obese subjects ages 4 to 21. A detailed assessment is performed on eligible subjects including fasting labwork, anthropometrics, nutrition analysis, body composition testing, echocardiography, and carotid IMT measurements.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2009-09 |
| Est. Completion | 2017-04-05 |
What the finished NCT03570840 record still lists
NCT03570840 is an observational study that tracks outcomes without assigning an intervention. The registered 477 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03570840 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03570840 about?
NCT03570840 is a clinical study titled "Pediatric Metabolic Syndrome Study". The Pediatric Metabolic Syndrome Study is an observational study being conducted at the Medical University of South Carolina to investigate cardiometabolic risk parameters in obese subjects ages 4 to 21. A detailed assessment is performed on eligible subjects including fasting labwork, anthropometri...
What is the current status of trial NCT03570840?
This trial is currently completed. The enrollment target is 477 participants. The study started on 2009-09. Estimated completion is 2017-04-05.
Who is sponsoring clinical trial NCT03570840?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03911700 · 477 participants · NA
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
- NCT06997497 · 477 participants · Phase 3
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- NCT05446272 · 478 participants · NA
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
- NCT06172296 · 478 participants · Phase 3
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia